遺伝子サイレンシングの世界市場レポート 2025年

遺伝子サイレンシング市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は12.9％で、109億5,000万米ドルに成長します。予測期間の成長は、希少疾患への応用拡大、デリバリーシステムの技術進歩、個別化医療への需要の高まり、政府の支援イニシアティブ、製薬企業とバイオテクノロジー企業のパートナーシップの拡大に起因しています。この期間に予想される主な動向には、標的遺伝子治療の開発、CRISPRに基づくサイレンシング・アプローチの台頭、希少疾患および希少疾病への注目の高まり、ナノ粒子送達技術の出現、遺伝子サイレンシングアプリケーションの農業への拡大などがあります。

遺伝性疾患の有病率の増加は、今後数年間の遺伝子サイレンシング市場の拡大を大きく促進すると予想されます。DNAの異常によって引き起こされる健康状態である遺伝子疾患は、診断技術の進歩、認知度の向上、遺伝子検査への幅広いアクセスにより、ますます検出されるようになってきています。遺伝性疾患の罹患率上昇の主な要因の1つは、親の年齢が上昇し、遺伝子の突然変異が子供に受け継がれる可能性が高まっていることです。遺伝子サイレンシングは、有害な遺伝子や病気を引き起こす遺伝子の発現を選択的に阻害することによって、遺伝性疾患に対処する有望な解決策を提示しています。例えば、英国を拠点とする慈善団体ダウン症UKによれば、ダウン症は英国で約4万人が罹患しており、約800人に1人の割合でダウン症の赤ちゃんが誕生しています。このような遺伝性疾患の有病率の増加が、遺伝子サイレンシング市場に拍車をかけています。

遺伝子サイレンシング市場の主要企業は、遺伝子治療の精度と有効性を向上させるため、小干渉RNA（siRNA）などの革新的技術の開発に注力しています。小分子干渉RNA（siRNA）は、特定のメッセンジャーRNA（mRNA）に結合してその分解を促進し、それによって病気の原因となるタンパク質の産生を防ぐRNA干渉（RNAi）経路で重要な役割を果たすRNA分子です。例えば、2024年10月、米国のバイオテクノロジー企業であるJudo Bio Inc.は、遺伝子を沈黙させるように設計された次世代siRNA薬を発売しました。このドラッグデリバリーには、脂質ナノ粒子や結合リガンドといった独自のデリバリーシステムが組み込まれており、特定の細胞や組織への効率的な取り込みを実現するとともに、潜在的な遺伝子ターゲットの同定を加速させるAI主導のプラットフォームも搭載されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の遺伝子サイレンシング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の遺伝子サイレンシング市場：成長率分析
• 世界の遺伝子サイレンシング市場の実績：規模と成長、2019年～2024年
• 世界の遺伝子サイレンシング市場の予測：規模と成長、2024年～2029年、2034年
• 世界の遺伝子サイレンシング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の遺伝子サイレンシング市場：タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 転写
• 転写後
• 減数分裂
• 世界の遺伝子サイレンシング市場：遺伝子サイレンシング別、実績と予測、2019年～2024年、2024年～2029年、2034年
• RNA干渉（RNAi）
• アンチセンスオリゴヌクレオチド（ASO）
• クラスター化された規則的に間隔を置いた短い回文反復配列（CRISPR）またはCas9ベースの遺伝子サイレンシング
• その他の遺伝子サイレンシング
• 世界の遺伝子サイレンシング市場：用途別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 神経学
• 腫瘍学
• 感染症
• 代謝性疾患
• 治療薬製造
• その他の用途
• 世界の遺伝子サイレンシング市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 製薬およびバイオテクノロジー企業
• 研究機関および学術センター
• 病院
• クリニック
• その他のエンドユーザー
• 世界の遺伝子サイレンシング市場、転写のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• DNAメチル化
• ヒストン修飾
• 世界の遺伝子サイレンシング市場、転写後サブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• RNA干渉（RNAi）
• アンチセンスオリゴヌクレオチド
• マイクロRNA（miRNA）によるサイレンシング
• 世界の遺伝子サイレンシング市場、減数分裂のサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 減数分裂遺伝子変換
• 転移因子サイレンシング

第7章 地域別・国別分析

• 世界の遺伝子サイレンシング市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の遺伝子サイレンシング市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 遺伝子サイレンシング市場：競合情勢
• 遺伝子サイレンシング市場：企業プロファイル
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Danaher Corporation
• Agilent Technologies Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Bio-Techne Corporation
• Alnylam Pharmaceuticals Inc.
• GenScript Biotech Corporation
• Oxford BioMedica plc
• Ionis Pharmaceuticals Inc.
• Arrowhead Pharmaceuticals Inc.
• Dicerna Pharmaceuticals Inc.
• New England Biolabs Inc.
• Quark Pharmaceuticals Inc.
• Sirion Biotech GmbH
• Benitec Biopharma Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 遺伝子サイレンシング市場2029年：新たな機会を提供する国
• 遺伝子サイレンシング市場2029年：新たな機会を提供するセグメント
• 遺伝子サイレンシング市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gene silencing is a biological process in which the expression of a specific gene is reduced or completely turned off. This process plays a crucial role in regulating gene activity, controlling development, and defending against viral infections. Gene silencing is essential in both research and medicine, particularly for targeting disease-related genes.

The main types of gene silencing include transcriptional, post-transcriptional, and meiotic. Transcriptional silencing refers to the regulation of gene expression at the transcription stage, where RNA is synthesized from a DNA template. Key gene silencing techniques include RNA interference (RNAi), antisense oligonucleotides (ASOs), and CRISPR/Cas9-based gene silencing, among others. These methods are applied across various fields such as neurology, oncology, infectious diseases, metabolic diseases, and therapeutic manufacturing. The primary end-users of gene silencing technologies include pharmaceutical and biotechnology companies, research institutes and academic centers, hospitals, clinics, and other related organizations.

The gene silencing market research report is one of a series of new reports from The Business Research Company that provides gene silencing market statistics, including the gene silencing industry global market size, regional shares, competitors with the gene silencing market share, detailed gene silencing market segments, market trends, and opportunities, and any further data you may need to thrive in the gene silencing industry. These gene silencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The gene silencing market size has grown rapidly in recent years. It will grow from $5.97 billion in 2024 to $6.75 billion in 2025 at a compound annual growth rate (CAGR) of 13.0%. The growth during the historic period can be attributed to the growing research in genetic therapies, early breakthroughs in RNA interference, the increasing prevalence of genetic disorders, rising investment in biotechnology, and the expanding biopharmaceutical manufacturing capabilities.

The gene silencing market size is expected to see rapid growth in the next few years. It will grow to $10.95 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the expanding applications in rare diseases, technological advancements in delivery systems, increasing demand for personalized medicine, supportive government initiatives, and growing partnerships between pharmaceutical and biotechnology companies. Major trends expected during this period include the development of targeted gene therapies, the rise of CRISPR-based silencing approaches, a greater focus on rare and orphan diseases, the emergence of nanoparticle delivery technologies, and the expansion of gene silencing applications into agriculture.

The growing prevalence of genetic disorders is expected to significantly drive the expansion of the gene silencing market in the coming years. Genetic disorders, which are health conditions caused by DNA abnormalities, are being increasingly detected due to advancements in diagnostic technologies, improved awareness, and wider access to genetic testing. One of the main contributors to the rising incidence of genetic disorders is the increasing age of parents, which raises the likelihood of genetic mutations being passed to their children. Gene silencing presents a promising solution for addressing genetic disorders by selectively inhibiting the expression of harmful or disease-causing genes. For example, according to Down Syndrome UK, a charity based in the UK, Down syndrome affects around 40,000 people in the UK, with approximately 1 in every 800 babies being born with the condition. This growing prevalence of genetic disorders is fueling the gene silencing market.

Leading companies in the gene silencing market are focusing on the development of innovative technologies, such as small interfering RNA (siRNA), to improve the precision and efficacy of gene therapy. Small interfering RNA (siRNA) is an RNA molecule that plays a key role in the RNA interference (RNAi) pathway by binding to specific messenger RNA (mRNA) and promoting its degradation, thereby preventing the production of disease-causing proteins. For instance, in October 2024, Judo Bio Inc., a biotechnology company based in the US, launched a next-generation siRNA drug designed to silence genes. The drug incorporates proprietary delivery systems, such as lipid nanoparticles or conjugated ligands, which ensure efficient uptake by specific cells or tissues, along with AI-driven platforms that accelerate the identification of potential gene targets.

In September 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, acquired Decibel Therapeutics for an undisclosed amount. This acquisition aims to strengthen Regeneron's genetic medicine and gene therapy capabilities, with a particular focus on developing treatments for sensory disorders, such as genetic hearing loss. Decibel Therapeutics, a US-based company, specializes in gene therapies for hearing loss, including its lead program, DB-OTO, which utilizes a gene silencing approach.

Major players in the gene silencing market are Roche Holding AG, Merck & Co. Inc., AstraZeneca plc, Novartis International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Bio-Techne Corporation, Alnylam Pharmaceuticals Inc., GenScript Biotech Corporation, Oxford BioMedica plc, Ionis Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., New England Biolabs Inc., Quark Pharmaceuticals Inc., Sirion Biotech GmbH, Benitec Biopharma Limited, GeneCopoeia Inc., Revvity Inc.

North America was the largest region in the gene silencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gene silencing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gene silencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gene silencing market consists of revenues earned by entities by providing services such as services such as gene knockdown assays, RNAi screening services, and epigenetic gene silencing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cholestatic pruritus market also includes sales of small interfering RNA, miRNA mimics and inhibitors, reporter assay kits, and therapeutic RNAi-based drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gene Silencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene silencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene silencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gene silencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Transcriptional; Post-Transcriptional; Meiotic
• 2) By Gene Silencing: RNA Interference (RNAi); Antisense Oligonucleotides (ASOs); Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing; Other Gene Silencings
• 3) By Application: Neurology; Oncology; Infectious Diseases; Metabolic Diseases; Therapeutics Manufacturing; Other Applications
• 4) By End-Users: Pharmaceutical And Biotechnology Companies; Research Institutes and Academic Centers; Hospitals; Clinics; Other End-Users
• Subsegments:
• 1) By Transcriptional: DNA Methylation; Histone Modification
• 2) By Post-Transcriptional: RNA Interference (RNAi); Antisense Oligonucleotides; MicroRNA (miRNA) Mediated Silencing
• 3) By Meiotic: Meiotic Gene Conversion; Transposable Element Silencing
• Companies Mentioned: Roche Holding AG; Merck & Co. Inc.; AstraZeneca plc; Novartis International AG; Thermo Fisher Scientific Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gene Silencing Market Characteristics

3. Gene Silencing Market Trends And Strategies

4. Gene Silencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gene Silencing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gene Silencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gene Silencing Market Growth Rate Analysis
• 5.4. Global Gene Silencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gene Silencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gene Silencing Total Addressable Market (TAM)

6. Gene Silencing Market Segmentation

• 6.1. Global Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Transcriptional
• Post-Transcriptional
• Meiotic
• 6.2. Global Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Interference (RNAi)
• Antisense Oligonucleotides (ASOs)
• Clustered Regularly Interspaced Short Palindromic Repeats(CRISPR) Or Cas9 -Based Gene Silencing
• Other Gene Silencings
• 6.3. Global Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neurology
• Oncology
• Infectious Diseases
• Metabolic Diseases
• Therapeutics Manufacturing
• Other Applications
• 6.4. Global Gene Silencing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Companies
• Research Institutes and Academic Centers
• Hospitals
• Clinics
• Other End-Users
• 6.5. Global Gene Silencing Market, Sub-Segmentation Of Transcriptional, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• DNA Methylation
• Histone Modification
• 6.6. Global Gene Silencing Market, Sub-Segmentation Of Post-Transcriptional, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• RNA Interference (RNAi)
• Antisense Oligonucleotides
• MicroRNA (miRNA) Mediated Silencing
• 6.7. Global Gene Silencing Market, Sub-Segmentation Of Meiotic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Meiotic Gene Conversion
• Transposable Element Silencing

7. Gene Silencing Market Regional And Country Analysis

• 7.1. Global Gene Silencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gene Silencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gene Silencing Market

• 8.1. Asia-Pacific Gene Silencing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gene Silencing Market

• 9.1. China Gene Silencing Market Overview
• 9.2. China Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gene Silencing Market

• 10.1. India Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gene Silencing Market

• 11.1. Japan Gene Silencing Market Overview
• 11.2. Japan Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gene Silencing Market

• 12.1. Australia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gene Silencing Market

• 13.1. Indonesia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gene Silencing Market

• 14.1. South Korea Gene Silencing Market Overview
• 14.2. South Korea Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gene Silencing Market

• 15.1. Western Europe Gene Silencing Market Overview
• 15.2. Western Europe Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gene Silencing Market

• 16.1. UK Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gene Silencing Market

• 17.1. Germany Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gene Silencing Market

• 18.1. France Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gene Silencing Market

• 19.1. Italy Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gene Silencing Market

• 20.1. Spain Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gene Silencing Market

• 21.1. Eastern Europe Gene Silencing Market Overview
• 21.2. Eastern Europe Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gene Silencing Market

• 22.1. Russia Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gene Silencing Market

• 23.1. North America Gene Silencing Market Overview
• 23.2. North America Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gene Silencing Market

• 24.1. USA Gene Silencing Market Overview
• 24.2. USA Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gene Silencing Market

• 25.1. Canada Gene Silencing Market Overview
• 25.2. Canada Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gene Silencing Market

• 26.1. South America Gene Silencing Market Overview
• 26.2. South America Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gene Silencing Market

• 27.1. Brazil Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gene Silencing Market

• 28.1. Middle East Gene Silencing Market Overview
• 28.2. Middle East Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gene Silencing Market

• 29.1. Africa Gene Silencing Market Overview
• 29.2. Africa Gene Silencing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gene Silencing Market, Segmentation By Gene Silencing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gene Silencing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gene Silencing Market Competitive Landscape And Company Profiles

• 30.1. Gene Silencing Market Competitive Landscape
• 30.2. Gene Silencing Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Gene Silencing Market Other Major And Innovative Companies

• 31.1. Danaher Corporation
• 31.2. Agilent Technologies Inc.
• 31.3. Illumina Inc.
• 31.4. Bio-Rad Laboratories Inc.
• 31.5. Bio-Techne Corporation
• 31.6. Alnylam Pharmaceuticals Inc.
• 31.7. GenScript Biotech Corporation
• 31.8. Oxford BioMedica plc
• 31.9. Ionis Pharmaceuticals Inc.
• 31.10. Arrowhead Pharmaceuticals Inc.
• 31.11. Dicerna Pharmaceuticals Inc.
• 31.12. New England Biolabs Inc.
• 31.13. Quark Pharmaceuticals Inc.
• 31.14. Sirion Biotech GmbH
• 31.15. Benitec Biopharma Limited

32. Global Gene Silencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gene Silencing Market

34. Recent Developments In The Gene Silencing Market

35. Gene Silencing Market High Potential Countries, Segments and Strategies

• 35.1 Gene Silencing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gene Silencing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gene Silencing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer